Amneal Pharmaceuticals
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 7.7K
- Market Cap
- $2.6B
- Website
- http://www.amneal.com
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 240
- Registration Number
- NCT06267274
- Locations
- 🇺🇸
Houston Eye Associates, Houston, Texas, United States
🇺🇸West Coast Eye Institute, Bakersfield, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
- Conditions
- Glaucoma, Open-AngleOcular Hypertension
- Interventions
- Drug: Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)Drug: Test - Bimatoprost 0.01% Ophthalmic Solution
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 168
- Registration Number
- NCT05401357
- Locations
- 🇺🇸
Eye Research Foundation Inc., Newport Beach, California, United States
🇺🇸Cheyenne Eye Clinic & Surgery Center, Cheyenne, Wyoming, United States
🇺🇸Toyos Clinic, Nashville, Tennessee, United States
BE Study in Patients - Methotrexate Tablets
- Conditions
- PsoriasisRheumatoid Arthritis
- Interventions
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2016-10-21
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02940561
- Locations
- 🇮🇳
Sterling Hospital, Ahmedabad, Gujarat, India
🇮🇳Saviour Hospital, Ahmedabad, Gujarat, India
🇮🇳Kanoria Hospital, Gandhinagar, Gujurat, India
Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo Nasal SprayDrug: Nasonex Nasal Spray, 50 mcgDrug: Mometasone Furoate Nasal Spray, 50 mcg
- First Posted Date
- 2014-04-29
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 811
- Registration Number
- NCT02125253
- Locations
- 🇺🇸
Austin Clinical Research, Austin, Texas, United States
🇺🇸Isis Clinical Research, Austin, Texas, United States
🇺🇸Sirius Clinical Research, Austin, Texas, United States
Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee
- Conditions
- Osteoarthritis
- Interventions
- Drug: Voltaren Topical Gel, 1%Drug: Vehicle Diclofenac Sodium Topical GelDrug: Diclofenac Sodium Topical Gel, 1%
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2021-06-16
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 1176
- Registration Number
- NCT02121002
- Locations
- 🇮🇳
Shree Giriraj Multispeciality Hospital, Rajkot, Gujurat, India
🇮🇳Rathi Orthopedic and Research Centre, Ahmedabad, Gujarat, India
🇮🇳Sunshine Hospitals, Secunderabad, Andhra Pradesh, India
Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions
- Conditions
- Primary HypogonadismHypogonadotropic Hypogonadism
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT02110368
- Locations
- 🇺🇸
Phase One Solutions, Inc., Miami Gardens, Florida, United States
Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions
- Conditions
- Chronic Myeloid LeukemiaGastrointestinal Stromal Tumor
- Interventions
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02103322
- Locations
- 🇮🇳
Kailash Cancer Hospital & Research Centre, Vadodara, Gujurat, India
🇮🇳Srinivasam Cancer Care Hospitals India Pvt., Bangalore, Karnataka, India
🇮🇳Lokmaya Hospital, Pune, Maharashtra, India
Bioequivalence Fasting Study in Patients
- First Posted Date
- 2014-02-27
- Last Posted Date
- 2014-06-27
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02072954
- Locations
- 🇮🇳
Divyam Hospital, Surat, Gujurat, India
🇮🇳Shri Hatkesh Healthcare Foundation, Junagadh, Gujurat, India
Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo
- Conditions
- Atrophic Vaginitis Due to Menopause
- Interventions
- Drug: Estradiol Vaginal Tablets 10 mcgDrug: placebo
- First Posted Date
- 2013-01-30
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 519
- Registration Number
- NCT01779947
- Locations
- 🇺🇸
Clinical Research of Philadelphia, LLC, Philadelphia, Pennsylvania, United States
🇺🇸Downtown Women's Health care, Denver, Colorado, United States
🇺🇸Meridian Health Care, Neptune, New Jersey, United States
Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)
- Conditions
- Uncomplicated Urinary Tract Infections
- Interventions
- First Posted Date
- 2012-07-26
- Last Posted Date
- 2014-06-26
- Lead Sponsor
- Amneal Pharmaceuticals, LLC
- Target Recruit Count
- 424
- Registration Number
- NCT01650051
- Locations
- 🇺🇸
Symbio, LLC, Port Jefferson, New York, United States